| Issue Date | Title | Author(s) |
| 2021-09 | Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects | Gulati, N; Chellappan, DK; MacLoughlin, R; Dua, K; Dureja, H |
| 2020-10-05 | Targeting interleukins in chronic airway diseases using advanced drug delivery. | Satija, S; Mehta, M; Gupta, G; Chellappan, DK; Dua, K |
| 2021-03-09 | Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio‐renal damage in COVID‐19 infection | Singh, Y; Ali, H; Alharbi, KS; Almalki, WH; Kazmi, I; Al‐Abbasi, FA; Anand, K; Dureja, H; Singh, SK; Thangavelu, L; Chellappan, DK; Dua, K; Gupta, G |
| 2021-10-05 | Berberine loaded liquid crystalline nanostructure inhibits cancer progression in adenocarcinomic human alveolar basal epithelial cells in vitro. | Mehta, M; Malyla, V; Paudel, KR; Chellappan, DK; Hansbro, PM; Oliver, BG; Dua, K |
| 2021-10-01 | Can dextran-based nanoparticles mitigate inflammatory lung diseases? | Prasher, P; Sharma, M; R Wich, P; Jha, NK; Singh, SK; Chellappan, DK; Dua, K |
| - | Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases | Chan, Y; Raju Allam, VSR; Paudel, KR; Singh, SK; Gulati, M; Dhanasekaran, M; Gupta, PK; Jha, NK; Devkota, HP; Gupta, G; Hansbro, PM; Oliver, BGG; Chellappan, DK; Dua, K |
| 2020-06-18 | SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection. | Singh, Y; Gupta, G; Kazmi, I; Al-Abbasi, FA; Negi, P; Chellappan, DK; Dua, K |
| - | Applications of drug-delivery systems targeting inflammasomes in pulmonary diseases | Devkota, HP; Paudel, KR; Jha, NK; Gupta, PK; Singh, SK; Chellappan, DK; Hansbro, PM; Dua, K |
| 2021-12 | Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives | Pattanayak, P; Singh, SK; Gulati, M; Vishwas, S; Kapoor, B; Chellappan, DK; Anand, K; Gupta, G; Jha, NK; Gupta, PK; Prasher, P; Dua, K; Dureja, H; Kumar, D; Kumar, V |
| 2021-10-15 | Protein and peptide delivery to lungs by using advanced targeted drug delivery. | Chellappan, DK; Prasher, P; Saravanan, V; Vern Yee, VS; Wen Chi, WC; Wong, JW; Wong, JK; Wong, JT; Wan, W; Chellian, J; Molugulu, N; Prabu, SL; Ibrahim, R; Darmarajan, T; Candasamy, M; Singh, PK; Mishra, V; Khurana, N; Shastri, MD; Satija, S; Zacconi, FC; Chakraborty, A; Mehta, M; Gupta, PK; Dureja, H; Gulati, M; Singh, SK; Gupta, G; Jha, NK; George Oliver, BG; Dua, K |
